Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. [electronic resource]
Producer: 20070327Description: e7 p. digitalISSN:- 1527-7755
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Doxorubicin -- therapeutic use
- Drug Administration Schedule
- Female
- Humans
- Lymphoma, AIDS-Related -- diagnosis
- Lymphoma, Non-Hodgkin -- diagnosis
- Male
- Prednisone -- therapeutic use
- Prognosis
- Rituximab
- Survival Analysis
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.